Molycop integration begins—watch the one-off costs and deleveraging credibility
Tega's transformational $1.5B Molycop acquisition closes June 1. Q1 FY27 will show the first month of consolidation, ~$30M in integration costs, and critically—management's path to sub-2.5x leverage within four years.
The Setup: One Month of Molycop, Heavy Integration Costs
Tega Industries completed its $1.5 billion acquisition of Molycop (a global grinding media leader for mining) on June 1, 2026. For Q1 FY-2027 (ended June 30), consolidated results will capture exactly one month of Molycop operations—from June 1 through month-end. This is a historic moment for Tega: the acquisition transforms it from a ₹8,950 Cr standalone miner into a bundled mining services powerhouse with 24 manufacturing sites globally. However, the print will be clouded by two material headwinds. First, ~$30 million in one-off transaction and refinancing costs will depress reported PAT. Second, consolidated leverage will spike: Molycop's existing $1 billion debt (now refinanced to $780M at lower cost) plus INR 1,500 Cr facility at Tega parent will land the combined entity at an estimated 4.0–4.5x Debt/EBITDA—a material jump from Tega's pre-acquisition ~0.3x. The critical read will be management's credibility on deleveraging: do they have a believable roadmap to sub-2.5x within four years?
~₹200–250 Cr
One month (June) only; full-quarter impact flows from Q2 onwards. Watch for exit run-rate color.
~₹250 Cr (~$30M)
Transaction, refinancing, separation, and integration charges. Expect management to itemize clearly.
~4.0–4.5x
Peak leverage in FY27 due to full-year Molycop debt plus refinancing. Path to 3.0–3.5x by FY28 critical to validate.
~3% YoY
Downgraded due to deferred mine restarts globally. Monitor for any further cuts or optimism on recovery timelines.
What a strong Q1 would look like: Molycop's one month contributes ₹200+ Cr in revenue, with EBITDA margins in line with expectations (~30%+). Management breaks out one-off costs transparently and reiterates FY27 pro-forma guidance with confidence. Critically, they articulate a clear deleveraging roadmap—asset sales timelines, EBITDA growth assumptions, and refinancing plans—that credibly gets to 3.5x by FY28 and sub-2.5x by FY30. Management also confirms customer wins and early synergy capture (bundled orders, cost eliminations). What a weak Q1 would look like: Molycop's contribution is lighter than expected, signaling integration or operational friction. One-off costs balloon beyond $30M or remain vague. Management provides no pro-forma guidance or fuzzy deleveraging targets ('we are focused on cash generation'), raising concerns about commitment to debt reduction. EBITDA margins compress or integration headwinds emerge. Leverage stays >4.5x with no credible path down, and FII selling resumes.
On Track? The Deleveraging & Integration Thesis
Tega's pre-acquisition FY26 revenue was ₹8,950.96 Cr. Standalone, the company has demonstrated steady mining services demand, but the TAM was historically capped at a regional player scale. Molycop—with $1.5B enterprise value and a global grinding media footprint—expands this universe dramatically. The strategic logic is sound: combine Tega's specialized mill liner technology with Molycop's scale, product breadth, and customer base to create a one-stop mining services shop. However, execution risk is material. The acquisition occurs in a weak global mining cycle (Molycop's own FY27 growth guidance is just 3%, down from prior expectations due to delayed mine restarts). CRISIL has downgraded Tega's credit rating post-acquisition due to elevated leverage, signaling the rating agencies' concern about near-term debt serviceability. The acid test for Q1 results: does management demonstrate that (a) Molycop is integrating smoothly, (b) synergies are materializing, and (c) a realistic multi-year deleveraging pathway exists? If management is vague or overly optimistic about growth offsetting debt burden, the market will punish the stock.
Since Last Quarter: Material Events & Filings
1 · Molycop Acquisition Close (June 1)
Deal completion with Apollo Funds consortium as co-investor. Molycop's existing $1B debt refinanced to $780M at lower cost (8.1–8.2%). INR 1,500 Cr facility drawn at Tega parent. First consolidated month appears in Q1 FY27 results. One-off costs of ~$30M (transaction, refinancing, separation) to impact Q1 PAT.
2 · New CFO Appointed (August 6)
Mr. Ravi Narayan Joshi (Chartered Accountant) appointed as CFO and KMP, effective immediately, replacing interim CFO (Ganguly) post-Khaitan resignation in April. First earnings call with new CFO; expect articulation of deleveraging strategy and capital allocation priorities.
3 · CRISIL Rating Downgrade
CRISIL downgraded Tega Industries' credit rating following the Molycop acquisition announcement due to elevated leverage and debt serviceability concerns. This signals rating agencies' caution on the debt burden; equity investors will watch for deleveraging credibility.
4 · Chile Subsidiary Tax Appeal Dismissed (July 15)
Tega Chile SpA's tax loss appeal upheld unfavorably. INR 8.73 Cr exposure on the books. Subsidiary issue; monitor for provision adjustments in Q1 results. Routine but noted.
5 · Australia Subsidiary De-registered (June 4)
Wholly-owned Tega Industries Australia Pty Ltd successfully de-registered. Clean exit from unprofitable jurisdiction; immaterial P&L impact.
6 · FY26 Final Dividend Approved (May 29)
Board approved ₹2 per share (20%) final dividend for FY26. Payout despite acquisition signals confidence in cash generation and shareholder returns; capital structure still allows dividends post-Molycop close.
What to Watch on August 13
1 · Molycop's June revenue, EBITDA, and margins
Expect a one-page breakdown of Molycop's Q1 contribution (June only). Watch for revenue, EBITDA, and margin %—are they in line with pre-acquisition expectations or showing integration friction? Exit run-rate (June actuals) will inform FY27 guidance.
2 · One-off costs—transparent itemization
The ~$30M charge must be clearly broken down: transaction costs, refinancing charges, separation costs, integration expenses. Vague or lumpy presentation raises red flags on hidden liabilities.
3 · FY27 pro-forma guidance & leverage roadmap
This is the acid test. Does management provide FY27 pro-forma guidance (combined revenue, EBITDA, PAT)? Do they articulate a credible multi-year deleveraging pathway—Debt/EBITDA targets, timing to sub-2.5x, and the sources (cash flow, asset sales, equity raises)? Vague guidance = re-rating risk.
4 · Consolidated leverage metrics & covenant headroom
Investors will scrutinize net debt/EBITDA (consolidated post-Molycop), interest coverage, and any covenant amendments. Tight headroom or refinancing risk = negative. Monitor debt maturity profile—are there near-term refinancing hurdles?
5 · Synergy realization & order book updates
Early wins matter: customer wins, bundled orders, cost synergies identified. Order book color (Tega + Molycop combined) and customer pipeline will indicate integration velocity and confidence in FY27 growth.
6 · Mine restart timelines & Molycop demand outlook
Given 3% FY27 growth guidance, management's color on global mining recovery, deferred mine restart timelines, and customer commentary will be critical. Any reduction in growth expectations = negative; any upside = re-rating catalyst.
Tega's Q1 FY27 is a pivotal quarter—the first official consolidation of a transformational acquisition that redefines the company's scale and ambition. The Street is cautiously constructive (₹1,930–₹2,084 target), but execution is uncertain. One-off costs will suppress reported earnings, leverage will spike to 4.0–4.5x (triggering CRISIL's downgrade), and global mining remains weak. The result will be overshadowed by one question: does management credibly demonstrate that Molycop is integrating well, synergies are real, and a pathway to sub-2.5x leverage within four years is achievable? If yes, the ₹2,000+ target is justified. If no—if guidance is vague, deleveraging timelines slip, or integration friction emerges—equity investors will take this as a warning signal. Watch the pro-forma guidance, the one-off cost itemization, and especially the deleveraging roadmap. That trifecta will set the next 12 months of valuation momentum.
Tega swings to ₹86 Cr consolidated loss in Q1FY27 on one-off Molycop deal costs
PAT -406.4% YoY · revenue +384% · margins compressing · miss vs street
₹1,723.44 Cr
+384% YoY
₹-108.25 Cr
-406.4% YoY
-6.22%
-15.7pp YoY
₹-11.47
Tega Industries' consolidated Q1 FY27 print — the first quarter to include Molycop Group, acquired for $1.5 billion and consolidated from 1 June 2026 — swung to a loss of ₹86.19 Cr attributable to owners (₹108.25 Cr including minority interest of ₹22.06 Cr), against profits of ₹35.34 Cr a year ago and ₹42.67 Cr last quarter. Consolidated EPS was -₹11.47 versus +₹5.31 YoY and +₹5.68 QoQ. Revenue jumped to ₹1,723.44 Cr (+384% YoY, +227% QoQ), but this is almost entirely inorganic: Molycop's newly created Grinding Media segment contributed ₹1,291.64 Cr in its first, partial month of consolidation, while the pre-existing Consumables-Others business grew a more modest ₹294 Cr to ₹397.18 Cr YoY and Equipments fell to ₹35.78 Cr from ₹64.32 Cr.
Q1 FY-2027 vs prior quarters
The loss traces to a known, flagged transition cost rather than operating weakness. Other expenses carried a one-time ₹190.96 Cr Molycop acquisition/advisory charge, finance costs jumped to ₹116.71 Cr from ₹5.09 Cr QoQ on roughly $838 million of new acquisition debt, and depreciation/amortisation rose to ₹73.62 Cr from ₹25.22 Cr QoQ as newly recognised intangibles (₹3,429.53 Cr, provisional) began amortising. Reported EBITDA margin collapsed to ~4.2% of total income from 15.6% YoY / 11.4% QoQ, but stripping out just the ₹190.96 Cr one-off, PBT would have been a profit of ~₹74.48 Cr and adjusted EBITDA margin ~15.2% — in line with the recent range. On that basis, adjusted PAT works out to roughly +134% YoY versus -406% reported, though even the adjusted number reflects one stub month of a newly added, much larger business rather than organic growth, so it isn't a like-for-like comparison. The standalone (pre-Molycop) business itself stayed healthy and largely insulated from deal costs, with PAT of ₹45.42 Cr, +18.3% YoY and +11.2% QoQ, and EPS of ₹6.05.
The stock went into the print at ₹1,545.7, down 5% over the past month of trading.
For context: revenue is at a 6-quarter high.
Management provided guidance for a 5% year-on-year revenue growth in FY26, with an adjusted EBITDA margin of 22%. The company expects continued strong performance in the equipment business (25% growth) and mid-to-high single-digit growth for consumables, targeting a 15%+ long-term CAGR for consumables. For FY27, Tega e
A Univest preview ahead of results had pegged Q1 revenue (ex-Molycop) at ₹359-413 Cr and PAT at ₹16-20 Cr, and had itself flagged roughly $30 million of one-off transaction/refinancing costs — directionally consistent with the ₹190.96 Cr charge actually booked, though the resulting swing to a loss is still a clear miss against that PAT estimate. Core (ex-Molycop) revenue of about ₹431.78 Cr came in at or just above the top of the street's ex-Molycop range. Management's FY27 guidance from the last concall (15% growth ex-Molycop, 3% for Molycop, 22% adjusted EBITDA margin, ~$55 million capex) cannot be fairly judged off one deal-cost-distorted, partial-consolidation quarter — this print is too early and too noisy to call a beat, miss, or in-line against that full-year target. The quarter's other developments — Tega Chile's tax loss appeal being dismissed (₹8.73 Cr exposure) and the appointment of Ravi Narayan Joshi as CFO on 6 August, just ahead of results — are minor relative to the Molycop integration and were not separately called out in the results themselves.
W1
Full three-month Molycop consolidation in Q2 FY27 — watch whether adjusted EBITDA margin holds near ~15% (Molycop itself guided at ~12% margin, 3% growth) and whether the ₹190.96 Cr transaction cost fully tapers off.
W2
Finance cost run-rate of ₹116.71 Cr this quarter against management's target to bring Molycop's leverage down to 3x within 3-4 years.
W3
Chile plant commissioning guided for early Q3 with revenue booking by Q4/next year (subject to regulatory approvals), and resolution of Tega Chile's ₹8.73 Cr tax exposure after its loss-carry-forward appeal was dismissed.